Use of magnetic resonance imaging to quantify fat and steatosis in the pancreas in patients after bariatric surgery : a retrospective study

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F22%3A00083474" target="_blank" >RIV/00023001:_____/22:00083474 - isvavai.cz</a>

Alternative codes found

RIV/00843989:_____/22:E0109843 RIV/65269705:_____/22:00076377 RIV/00098892:_____/22:10157158 RIV/00216224:14110/22:00128219 and 3 more

Result on the web

<a href="https://www.scopus.com/record/display.uri?origin=resultslist&eid=2-s2.0-85138246330" target="_blank" >https://www.scopus.com/record/display.uri?origin=resultslist&eid=2-s2.0-85138246330</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s11695-022-06278-4" target="_blank" >10.1007/s11695-022-06278-4</a>

Result language

angličtina

Original language name

Use of magnetic resonance imaging to quantify fat and steatosis in the pancreas in patients after bariatric surgery : a retrospective study

Original language description

Introduction Pancreatic steatosis (PS) has both metabolic consequences and local effects on the pancreas itself. Magnetic resonance imaging (MRI) is the most reliable non-invasive method for diagnosing PS. We investigated the impact of metabolic syndrome (MS) on the presence of PS, differences in individuals with and without PS, and the metabolic effects of bariatric procedures. Methods Changes in anthropometric and basic biochemistry values and MS occurrence were evaluated in 34 patients with obesity who underwent a bariatric procedure. After the procedure, patients underwent MRI with manual 3D segmentation mask creation to determine the pancreatic fat content (PFC). We compared the differences in the PFC and the presence of PS in individuals with and without MS and compared patients with and without PS. Results We found no significant difference in the PFC between the groups with and without MS or in the occurrence of PS. There were significant differences in patients with and without PS, especially in body mass index (BMI), fat mass, visceral adipose tissue ( VAT), select adipocytokines, and lipid spectrum with no difference in glycemia levels. Significant metabolic effects of bariatric procedures were observed. Conclusions Bariatric procedures can be considered effective in the treatment of obesity, MS, and some of its components. Measuring PFC using MRI did not show any difference in relation to MS, but patients who lost weight to BMI &lt; 30 did not suffer from PS and had lower overall fat mass and VAT. Glycemia levels did not have an impact on the presence of PS.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30224 - Radiology, nuclear medicine and medical imaging

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2022

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Obesity surgery

ISSN

0960-8923

e-ISSN

1708-0428

Volume of the periodical

32

Issue of the periodical within the volume

11

Country of publishing house

US - UNITED STATES

Number of pages

9

Pages from-to

3666-3674

UT code for WoS article

000859286600001

EID of the result in the Scopus database

2-s2.0-85138246330